Relation between serum phosphate level and cardiovascular event rate in people with coronary disease.
about
Guidelines for the management of chronic kidney diseaseHyperphosphatemia Management in Patients with Chronic Kidney DiseaseThe role of phosphorus in the development and progression of vascular calcificationMiscellaneous non-inflammatory musculoskeletal conditions. Hyperphosphatemic familial tumoral calcinosis (FGF23, GALNT3 and αKlotho)Arterial calcification in chronic kidney disease: key roles for calcium and phosphateCan serum levels of alkaline phosphatase and phosphate predict cardiovascular diseases and total mortality in individuals with preserved renal function? A systemic review and meta-analysisVascular calcification--is aldosterone a culprit?Phosphorus and the kidney: What is known and what is neededA potential link between phosphate and aging--lessons from Klotho-deficient miceCalcium and phosphate impact cardiovascular risk.Vascular calcification: When should we interfere in chronic kidney disease patients and how?Molecular Mechanisms of Vascular Calcification in Chronic Kidney Disease: The Link between Bone and the VasculatureNHE3 regulatory factor 1 (NHERF1) modulates intestinal sodium-dependent phosphate transporter (NaPi-2b) expression in apical microvilliThe systemic nature of CKD.NFκB-sensitive Orai1 expression in the regulation of FGF23 release.Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKDAssociation of serum phosphate levels with aortic valve sclerosis and annular calcification: the cardiovascular health study.Fibroblast growth factor 23 and Klotho: physiology and pathophysiology of an endocrine network of mineral metabolismHigh dietary phosphorus intake is associated with all-cause mortality: results from NHANES III.Prevalence and prognostic impact of chronic kidney disease in STEMI from a gender perspective: data from the SWEDEHEART register, a large Swedish prospective cohort.Longitudinal relationships among coronary artery calcification, serum phosphorus, and kidney function.Intestinal npt2b plays a major role in phosphate absorption and homeostasis.Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin.Phosphate and cardiovascular diseaseThe emerging role of phosphate in vascular calcification.Association of serum phosphorus with left ventricular mass in men and women with stable cardiovascular disease: data from the Heart and Soul Study.Dietary phosphorus, blood pressure, and incidence of hypertension in the atherosclerosis risk in communities study and the multi-ethnic study of atherosclerosisInvolvement Of Vascular Aldosterone Synthase In Phosphate-Induced Osteogenic Transformation Of Vascular Smooth Muscle Cells.Nutritional Intervention Incorporating Expedited 10 g Protein Counter (EP-10) to Improve the Albumin and Transferrin of Chronic Hemodialysis Patients.Nutrients Turned into Toxins: Microbiota Modulation of Nutrient Properties in Chronic Kidney Disease.Association of dietary phosphorus intake and phosphorus to protein ratio with mortality in hemodialysis patients.Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial.Is controlling phosphorus by decreasing dietary protein intake beneficial or harmful in persons with chronic kidney disease?Serum phosphorus levels and the spectrum of ankle-brachial index in older men: the Osteoporotic Fractures in Men (MrOS) studySerum alkaline phosphatase and phosphate and risk of mortality and hospitalizationEffect of niacin on FGF23 concentration in chronic kidney disease.No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease.Fibroblast growth factor 23 and mortality among patients undergoing hemodialysisPhosphorus supplement alters postprandial lipemia of healthy male subjects: a pilot cross-over trialFibroblast growth factor-23 in early chronic kidney disease: additional support in favor of a phosphate-centric paradigm for the pathogenesis of secondary hyperparathyroidism.
P2860
Q24657844-E0D8583F-1D36-4C3E-95B0-A8DAFC90E558Q26743842-DA34AFBA-9083-48B4-AF76-3DDE8CE06E27Q26823897-800C06FF-D2D2-4C33-B17A-82AC1AA684FCQ26827280-272E8250-878E-438B-9E9D-EB8CBF143355Q26827655-4CDA2B55-E36E-4427-BEEC-587E227E61AEQ26851216-02F8359B-8F2B-4405-8399-3840EDE975FAQ26851687-9E46A3D1-A21C-4BAA-82CC-C7EEAE06D88EQ26992251-C940E286-3EC1-49F9-813E-5479CD0A77F8Q27687316-1ABADEC1-00C1-4EF8-9627-2462E3A0CE9BQ27687570-CA9A44AF-7BFA-4242-9C7B-9DBB0A36D03BQ28071582-81066C86-6659-47C9-BFC5-105C6BAA526AQ28087423-C0B6DF85-A2AE-4936-AAD8-3EB9102EB8B3Q28566881-5279B282-F221-4AD9-BAE1-9285B41FDEA2Q30234695-06F3E29F-00A8-427F-988A-B511130D35B0Q30315916-44A04BED-1D64-44E2-985E-A13D1376B4F2Q30429870-EAE616C8-6E37-49F2-899B-F35D42AA3B56Q30503036-0D7A0BF2-069A-4B24-9323-61D00DC46F78Q30544587-9DA68617-9A07-4B1B-B025-548E51C988A0Q30564821-355C48EF-EBA0-45CF-9A2E-CB5971A79A68Q30976231-CBF75656-8B01-459D-B04E-FECCDC19590AQ33560460-782423B4-1968-4281-97FA-27B7AFB2C96FQ33561684-4A734840-E921-48A3-B5EC-B82ECDDBC62EQ33562017-48FC6F12-9201-43F0-A295-B68D501FA22BQ33566596-37E4B554-F503-46E2-95BF-E33D653913C7Q33595584-656BC0B5-D9FA-4629-94A2-13C2F3491CC1Q33617174-05FFF673-1552-4D39-B85F-B2377BB3A2EBQ33672499-00D69089-CD73-415C-8283-0118671F95A7Q33700483-0281DD52-92CC-4BE4-AACB-4BDF1AB0F8FFQ33710275-65B5BDF1-ED20-4378-BCB3-DF66ED514D29Q33749467-A336C764-CF5D-4A47-B86B-72931FC4BD27Q33769983-41A425A5-5EA0-4BB8-AD7A-2E14CDA067F6Q33770086-05ADB228-0659-4F3F-A79D-0E2103212732Q33880308-BD83F061-1358-4F43-A70C-FB6CD9A036EBQ33880783-9C35F4C7-1F2E-4974-B6B9-99A36CF449BDQ33888428-222FFF1D-0F82-4227-B465-48107D695140Q33914268-C6B80B52-DA1F-4DEB-A454-F49643C84CCDQ33920648-3CB35613-56C0-4DA8-ACC4-E628C56FA6B5Q33932297-7D3CFE2A-93E8-4C6C-B5C0-26E0954D2A85Q33943512-92278838-8AEB-431B-9140-C22A6B7D4154Q33944788-95F00D19-19B6-4BA3-A230-98EDB1B41943
P2860
Relation between serum phosphate level and cardiovascular event rate in people with coronary disease.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Relation between serum phospha ...... people with coronary disease.
@en
Relation between serum phospha ...... people with coronary disease.
@nl
type
label
Relation between serum phospha ...... people with coronary disease.
@en
Relation between serum phospha ...... people with coronary disease.
@nl
prefLabel
Relation between serum phospha ...... people with coronary disease.
@en
Relation between serum phospha ...... people with coronary disease.
@nl
P2093
P1433
P1476
Relation between serum phospha ...... people with coronary disease.
@en
P2093
Cholesterol And Recurrent Events Trial Investigators
Frank Sacks
Gary Curhan
Marc Pfeffer
Zhiwei Gao
P304
P356
10.1161/CIRCULATIONAHA.105.553198
P407
P577
2005-10-01T00:00:00Z